600664 Harbin Pharmaceutical Group
- 3.94
- -0.02-0.51%
About Harbin Pharmaceutical Group Company
The company is a large enterprise group integrating pharmaceutical manufacturing, trading and scientific research. Listed on the Shanghai Stock Exchange in June 1993, it is the first listed company in the national pharmaceutical industry and the first listed company in Heilongjiang Province. The company is mainly engaged in pharmaceutical R&D and manufacturing, wholesale and retail business. The company's main products include compound calcium gluconate oral solution, Harbin Yao brand calcium iron zinc oral solution, human erythroprotin injection, amoxicillin capsules, Shuanghuanglian oral solution, Puxue brand iron vitamin B12 oral solution, ceftriaxone sodium for injection, bone pain gel cream, and lacidipine tablets. Corporate honors: It has successively won honors such as “Top 100 Enterprises in the National Pharmaceutical Industry”, “China's Most Socially Responsible Pharmaceutical Enterprise”, “China's Top Ten Leading Pharmaceutical Brand Enterprises”, “China Pharmaceutical Quality Management Award”, and “Heilongjiang Provincial Government Quality Award”.
Company Profile
Company Executives
- Name
- Position
- Salary
- xiaoping hu
- Chairman, Directors, Chairman of the Strategy and Decision Committee, Member of the Remuneration and Assessment Committee
- --
- mo liu
- Directors, Nomination Committee Members
- --
- zhifeng sun
- Directors, Member of the Strategy and Decision Committee
- --
- shiwei yin
- Directors, Audit Committee Member
- --
- chuanyou lu
- Directors, President, Member of the Strategy and Decision Committee
- 1.39M
- weihong lu
- Independent Directors, Nomination Committee Members, Member of the Remuneration and Assessment Committee
- 150.00K
- aidong lou
- Independent Directors, Chairman of the Remuneration and Assessment Committee, Audit Committee Member
- 150.00K
- zhaohua li
- Independent Directors, Chairman of the Audit Committee
- 150.00K
- ying lei
- Independent Directors, Chairman of the Nomination Committee
- --
- xiaodong meng
- Board Secretary, Deputy General Manager, Head of Finance
- 1.14M
- kunyu ma
- Securities Affairs Representative
- --
- wenguang peng
- Chairman of the Supervisory Board, Auditors
- 374.60K
- cheng peng
- Auditors
- --
- jicheng xia
- Deputy General Manager
- 756.20K
- haitao jiang
- Deputy General Manager
- 982.50K
- bangdong li
- Deputy General Manager
- 752.50K
- fangju qiu
- Employee Supervisors
- 279.00K
Analysis
Price Target
No Data
No Data